|Chemical and physical data|
|Molar mass||193.12 g/mol g·mol−1|
|3D model (JSmol)|
Sabcomeline (Memric; SB-202,026) is a selective M1 receptor partial agonist that was under development for the treatment of Alzheimer's disease. It made it to phase III clinical trials before being discontinued due to poor results.